Incheon
South Korea
38
2025-08-21
31
2026-01-27
These are the the leading inventors for applications assigned to CELLTRION, INC.:
CELLTRION, INC. based in Incheon, KR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Clinical Supplies Management Method And Device Using Same
#2 | 2025-03-13Expression Cassette for Production of High-Expression and High-Functionality Target Protein and Use Thereof
#3 | 2024-10-31STABLE LIQUID FORMULA
#4 | 2024-08-29 ✅ Patent 12,534,738 granted on 2026-01-27EXPRESSION CASSETTE INCLUDING INTRON FOR HIGH EXPRESSION OF PROTEIN OF INTEREST AND USE THEREOF
#5 | 2024-02-29Immunogenic Composition Comprising Multivalent Streptococcus Pneumoniae Polysaccharide-Protein Conjugates
#6 | 2023-06-22 ✅ Patent 12,551,465 granted on 2026-02-17PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION
#7 | 2023-04-20 ✅ Patent 12,533,343 granted on 2026-01-27NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE
#8 | 2023-03-23 ✅ Patent 12,486,237 granted on 2025-12-02Polymorphic Form of (-)-Cibenzoline Succinate
#9 | 2023-02-09Pharmaceutical Formulation Comprising Cibenzoline or Salt Thereof
#10 | 2022-06-09Binding Molecule Having Neutralizing Activity Against Middle East Respiratory Syndrome-Coronavirus
#11 | 2021-12-30 ✅ Patent 12,157,764 granted on 2024-12-03Dosing regimen for treating influenza virus diseases
#12 | 2021-12-23 ✅ Patent 12,419,863 granted on 2025-09-23PHARMACEUTICAL COMPOSITION FOR USE IN TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY
#13 | 2021-11-11 ✅ Patent 12,065,482 granted on 2024-08-20Stable liquid pharmaceutical formulation of anti-influenza virus antibody
#14 | 2021-10-14 ✅ Patent 11,730,698 granted on 2023-08-22Stable liquid pharmaceutical preparation
#15 | 2021-07-08 ✅ Patent 11,986,523 granted on 2024-05-21Stable liquid formula comprising anti-TNFa antibody, acetate buffer, and glycine
#16 | 2021-01-07 ✅ Patent 11,951,207 granted on 2024-04-09Stable liquid pharmaceutical preparation
#17 | 2020-09-24 ✅ Patent 12,188,036 granted on 2025-01-07Expression cassette for production of high-expression and high-functionality target protein and use thereof
#18 | 2019-11-14 ✅ Patent 10,980,881 granted on 2021-04-20Stable liquid formula having an anti-TNFalpha antibody, acetate buffer and glycine
#19 | 2019-08-15 ✅ Patent 11,236,146 granted on 2022-02-01Stable pharmaceutical formulation
#20 | 2019-06-27 ✅ Patent 10,947,497 granted on 2021-03-16callus extract having increased content of gallic acid, method for preparing same, and whitening cosmetic composition containing same
#21 | 2019-04-18 ✅ Patent 11,007,136 granted on 2021-05-18Cosmetic composition for wrinkle reduction containing gypenoside isolated from
#22 | 2019-01-24 ✅ Patent 10,722,571 granted on 2020-07-28Rabies virus G protein epitope, and rabies virus neutralising binding molecule that binds specifically thereto
#23 | 2019-01-03 ✅ Patent 10,610,587 granted on 2020-04-07Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
#24 | 2018-07-05 ✅ Patent 11,202,751 granted on 2021-12-21Whitening cosmetic composition comprising root extract
#25 | 2018-06-14 ✅ Patent 11,712,407 granted on 2023-08-01Hybrid-type multi-lamellar nanostructure of epidermal growth factor and liposome and method for manufacturing same
#26 | 2018-01-11ADJUVANT COMPOSITION CONTAINING AT LEAST ONE INFLUENZA VIRUS NEUTRALIZING AND BINDING MOLECULE AND VACCINE COMPOSITION CONTAINING SAME
#27 | 2017-11-16 ✅ Patent 10,507,240 granted on 2019-12-17Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus
#28 | 2017-09-14 ✅ Patent 10,239,902 granted on 2019-03-26Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
#29 | 2017-06-08 ✅ Patent 9,834,594 granted on 2017-12-05Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
#30 | 2017-02-09 ✅ Patent 9,856,312 granted on 2018-01-02Binding molecule having influenza A virus-neutralizing activity produced from human B cell
#31 | 2016-09-15 ✅ Patent 10,351,592 granted on 2019-07-16Method for separating antibody isoforms using cation exchange chromatography
#32 | 2015-12-24 ✅ Patent 9,814,784 granted on 2017-11-14Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same
#33 | 2015-08-13 ✅ Patent 9,278,996 granted on 2016-03-08Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
#34 | 2014-08-21 ✅ Patent 9,475,861 granted on 2016-10-25Binding molecule having influenza A virus-neutralizing activity produced from human B cell
#35 | 2013-02-21 ✅ Patent 9,024,000 granted on 2015-05-05Method to improve the sorbent efficiency of protein A chromatography using switching column with continuous feeding
#36 | 2013-01-03 ✅ Patent 9,573,991 granted on 2017-02-21Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
#37 | 2012-01-12 ✅ Patent 9,309,519 granted on 2016-04-12Method for selecting a high expression recombinant cell line
#38 | 2011-03-17 ✅ Patent 8,361,790 granted on 2013-01-29Human host cell for producing recombinant proteins with high quality and quantity
Also check out CELLTRION INC.'s (Incheon, South Korea) applicant profile with 35 patent applications submitted.
1541 ⎘